The patients who were female, nonsmokers, had an ECOG PS of 0, had a pathological type of ADC, had a KRAS mutation in exons other than exon 2, had prior treatment of 1 line, or had <3 metastases received greater PFS benefits (Supplementary Table 2). The gene discussed is KRAS; the disease is AIDS dementia complex.